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Myasthenia gravis is an autoimmune disease characterized by circulating auto- 
antibodies against the acetylcholine receptor (AChR) ~ present on the neuromus- 
cular endplate.  It is generally believed that these antibodies are responsible for 
an  accelerated  rate  of AChR  degradation,  leading  to  muscular  weakness and 
fatiguability (1).  To date,  treatment  has  involved either  the  administration  of 
anticholinesterases  or  nonspecific  immunosuppressive  measures.  Ideally,  one 
would like to specifically eliminate  the anti-AChR  autoimmune  response while 
not affecting the host's general immune status. Attempts to specifically suppress 
the anti-AChR immune response by nonmyasthenic derivatives of AChR (2) and 
by induction  of antiidiotype (3) have been reported.  Moreover, a recent report 
indicates  that  anti-AChR  antibody  levels in  mice  can  be suppressed  if anti-Ia 
monoclonal antibodies are administered (4). 
It has been suggested that the underlying defect in myasthenia gravis (as well 
as other autoimmune diseases) is a deficiency of suppressor T  cells (5).Therefore, 
specific treatment of myasthenia gravis might be achieved if a suitable source of 
antigen  (AChR)-specific suppressor T  cells and  their  secreted factors could be 
developed. To date, however, no model system has yet been developed demon- 
strating a  means for induction  of AChR-specific suppressor T  cells.  In light of 
its potential importance to the human disease, we have established the conditions 
to induce AChR-specific suppressor T  cells capable of suppressing the in vitro 
anti-AChR response. Moreover, we demonstrate that this suppressive effect can 
be mediated by a secreted factor found in the cell-free supernatant. 
A key aspect of this work involved the development of an appropriate in vitro 
anti-AChR  assay.  The  AChR-induced  lymphoproliferative assay (6) was found 
unsuitable for the work described here. Therefore, we applied the assay described 
by Mishell and Dutton (7) to the AChR antigenic system. This assay is relatively 
well-characterized in other systems and permits analysis of immunoregulatory T 
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cells and their secreted  factors.  In this paper we report the details of the assay 
and  its application  for measuring  AChR-specific  suppressor T  cell  (Ts) and  T 
cell factors (TsF). We believe that this is the first report of a suppressor factor to 
a physiologically and pathologically important autoantigen whose role in a human 
autoimmune disease is well-defined. 
Materials and  Methods 
Mice and Immunizations.  C57BL/6J female mice 6 wk of age were obtained from The 
Jackson Laboratory, Bar Harbor, ME. They were rested at least 1 wk before immunization 
with 10-15 #g AChR emulsified in complete Freund's adjuvant (CFA; Difco Laboratories, 
Detroit, MI) administered to the two hind-foot pads. These mice were used 10-30 d later 
without boosting for the Misheil-Dutton assay. 
Isolation of AChR.  AChR  was isolated from the electric organs of Torpedo californica 
according to the procedure of Aharanov et al. (8) with several modifications. Elution of 
AChR from the Sepharose-Naja-naja siamensis toxin column was done in 0.025% Triton 
X-100 instead of 0.1%, except for the batch conjugated with nitroiodophenol (NIP). Also, 
the dialysis after elution  was done without  EDTA and sodium azide and with  0.025% 
Triton X-100 in Tris-buffered saline using twice-distilled water. 
Coupling of Nitroiodophenol (NIP)  to AChR.  20  #1  of 4-hydroxy-5-iodo-3-nitrophenyl 
(NIP)-O-succinimide (20  mg/ml) dissolved in  dimethylformamide was added  to  10  mg 
AChR dissolved in 5 ml of 0.12  M carbonate buffer pH 9.2,  with 0.1%  Triton X-100. 
The mixture was incubated for 20 min at room temperature and then dialyzed to remove 
nonreacted  NIP-O-succinimide. Absorbance at 430 nm indicated a  substitution ratio of 
20 NIP groups per AChR. By SDS-PAGE as well as l~SI-bungarotoxin binding, the NIP- 
AChR was indistinguishable from the unmodified AChR. Moreover, all education proce- 
dures in vivo or in vitro always employed the unmodified AChR, whereas NIP-AChR was 
used only to trigger a secondary response in vitro. 
In  Vitro Secondary Anti-AChR  Response.  AChR-immune animals were  used  10-30  d 
after one  immunization.  Poor responses were  obtained after longer  intervals or after 
boosting. Cells from draining lymph nodes and spleen were washed twice and resuspended 
in  RPMI  1640  with  10%  heat-inactivated  fetal calf serum  (FCS)  (batch #607;  Biolab, 
Jerusalem), 2 mMglutamine,  10 mM Hepes, 5 ×  10 -s M 2-ME,  1 #M sodium pyruvate, 
and antibiotics. 106 viable lymphocytes were placed in each well of a 96-well Microtitre II 
tray (Falcon #3040). Each culture consisted of 3-6 replicate wells in a final volume of 0.2 
ml. NIP-AChR was added to the cell suspension at a concentration of 0.2 #g/ml, unless 
otherwise indicated.  At this concentration,  toxicity due to the Triton X-100  detergent 
was negligible. Cells were cultured at 37°C,  5% CO2 in air for 5 d  and were not given 
any feeding during that time. On day 5, individual groups were collected and washed and 
indirect plaque-forming cell (PFC) responses were assayed by the Cunningham modifica- 
tion of the Jerne plaque assay (9).  Four replicate counts were done per gr.  oup and the 
mean _  standard error calculated. In this assay, therefore, we are measuring a primary 
anti-NIP B cell response (hapten) induced by a  secondary T  cell response to the AChR 
(carrier). 
Primary Induction ofAChR-specific Ts Cells.  Splenocytes from naive C57BL/6 mice were 
cultured in  RPMI  1640  with  10%  FCS  (Gibco  Laboratories,  Grand  Island,  NY)  and 
supplements as described  above.  The batch of FCS  was critical  in  order  to  minimize 
nonspecific (serum-specific) suppression (10). Cells were aliquoted 5 ×  108 lymphocytes/ 
well to a 24-well plate (Costar #3524),  1 ml per well. AChR was added to a concentration 
of 4  #g/ml  and  the  culture  incubated  for 4-5  d.  Cells  were  then  collected,  washed, 
counted, and replated in an anti-AChR in vitro assay. Usually, 50-60% of the cells were 
recovered after this culture with many blast cells present. 
Production of Ts Factor  from In Vitro-educated AChR-Ts Cells.  In vitro-educated Ts cells 
were harvested on day 4, washed twice, and resuspended in RPMI-1640 plus supplements 
but without serum. 5 ×  106 viable cells were aliquoted per well of a Costar 24-well plate 
in 1 ml and NIP-AChR added to 0.2 #g/ml. The following day supernatants were collected, 294  SUPPRESSION  OF  IN  VITRO  ACETYLCHOLINE  RECEPTOR  RESPONSE 
filtered, and stored at -20°C. 
In Vivo-educated Ts Cells and Factor.  Mice were injected with 100 #g AChR in PBS i.p. 
and used  1 wk later or boosted with an identical dose at 2 wk and used the following 
week. TsF was obtained by culturing splenocytes in RPMI  1640 with supplements (as in 
the assay),  107 cells per well in 1 ml in a Costar 24-well plate. Cells were incubated for 2 
d, at which time the supernatants were collected, filtered, and stored at -20°C. 
Affinity Columns.  Sepharose-AChR and Sepharose-FCS columns were prepared accord- 
ing to techniques already described (11). Briefly, cyanogen bromide-activated Sepharose 
was mixed either with AChR (2 mg/g Sepharose) or FCS (1 ml, dialyzed into 1 M NaHCOs 
per 5 g Sepharose). Supernatants containing TsF were passed through such columns and 
binding allowed to take place for 30 min at room temperature. Columns were extensively 
washed with PBS and the elution done in 0.2 M NH4OH. Eluates were quickly brought 
to pH 8-9 by addition of NaHCO3 and were dialyzed against RPMI medium. 
Enrichment of AChR-specific Proliferating Cells.  Cells  from draining lymph nodes were 
washed and resuspended in RPMI  1640 supplemented with 2.5% horse serum,  10 mM 
He  pes, 2 mM glutamine, 5 ×  10  -5 M 2-ME, and antibiotics. Cells were aliquoted, 5.5 × 
109 cells per well in a 96-well tray, and AChR was added to a concentration of 2 #g/ml. 
After a 3-d culture, viable cells were separated by Lymphoprep centrifugation (Nyegaard 
land Co.,  density =  1.077 g/cm3), washed, and resuspended in medium for use in the 
Mishell-Dutton assay as indicated in the text. 
Antisera and Complement Treatment.  Two monoclonal IgM rat-mouse hybridomas were 
used for cell fractionation, anti-Thy-l.2 (AT83A) and anti-Lyt-2 (3.155). Both were the 
generous gift of Dr. Frank Fitch, Department of Pathology of The University of Chicago. 
Lymph node cells were resuspended in a 1:3 dilution of hybridoma supernatants, 5 ×  106 
cells/ml, and incubated for 30 min at 4°C. Cells were then spun down and resuspended 
in a  1:10  dilution of guinea pig complement (Gibco). Complement was  detoxified by 
sequential absorptions on sheep erythrocytes (SE) (5 ml complement to 1 ml packed SE) 
and naive splenocytes (1 ml complement to 1 spleen), each for 30 rain at 4°C. Afterwards, 
cells were washed, counted, and added to the Mishell-Dutton assay in a volume of 50 #1. 
Panning of Cells.  In order to enrich or deplete certain cell populations, a procedure 
based on that used by Mage et al. (12) was used. Adherent cells and B cells were depleted 
by incubation of cells for 1 h at room temperature on a goat anti-mouse Ig (300 #g/ml, 
affinity purified) coated plate (60 ×  15 ram, Falcon #3002). Cells bearing receptors for 
proteins present in FCS were fractionated by an additional incubation in a  FCS-coated 
plate (20% FCS in PBS). Adherent cells were recovered by chilling the plate at 4°C for 
15 min and vigorous pipetting. 
Results 
Secondary Stimulation of  AchR-Immune Helper T Cells--Assay Parameters.  Lymph 
node cells from AChR-immune  mice (injected into the hind-foot pads) demon- 
strated strong helper activity when cultured in vitro with B cells and NIP-AChR. 
These helper T  cells were able to stimulate  NIP-specific B  cells present in the 
lymph  nodes  and  spleen  to  produce  antibody  which  could be  measured  in  a 
hemolytic plaque assay using  NIP-coated  SE.  This assay thus represents a  sec- 
ondary  response  to  the  carrier  (AChR),  whereas  the  B  cell  hapten-specific 
response (anti-NIP) is primary. Several parameters were found to be important, 
i.e., antigen (NIP-AChR) concentration, cell density, and culture kinetics. These 
parameters were calibrated (Table I) and the optimal conditions were found to 
be 0.2 #g/ml  NIP-AChR,  1 ×  10  6 cells/well for a  culture period of 5  d.  These 
conditions were always used unless otherwise indicated. The cause of the dramatic 
drop in PFC responses on day 6  in the kinetics experiment is due to cell death. 
Role of AChR-spec~c  "Proliferating" Cell.  In order to characterize the AChR- 
specific helper T  cell and its relationship to the "proliferating cell" measured in BOGEN,  MOZES,  AND  FUCHS 
TABLE  I 
Parameters of Anti-AChR Assay 
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NIP-AChR  Cells/well  Day of  PFC/Culture  assay 
#g/ml 
2.0  1 X 106  5  2,328 ±  216 
0.2*  3,306 ±  384 
0.02  3,120 ±  282 
0.002  1,704 ±  204 
0.0002  1,638 ±  156 
None*  252 ±  57 
0.2  2.5 X 105  5  190 ±  78 
None  530 ±  110 
0.2  5 x  l0 S  1,036 ±  198 
None  414 ±  58 
0.2  7.5 X 105  1,805 ±  102 
None  766 ±  54 
0.2  1 ×  106.  2,355 ±  240 
None  489 ±  23 
0.2  1 x  106  3  3,540 +  360 
None  1,900 +  335 
0.2  4  3,798 ±  666 
None  1,638 ±  138 
0.2  5*  3,306 ±  384 
None  252 +  57 
O.2  6  252 ±  72 
None  140 ±  37 
* Optimal conditions of this parameter. 
* An irrelevant antigen (NIP-HGG, 0.5 t~g/ml)  was also checked and 
be nonstimulatory. PFC =  930 +- 96 (data not shown). 
found to 
TABLE  II 
Characteristics of AChR-specific Helper T Cells 
Treatment of AChR-immune cells 
NIP- 
AChR 
added in 
vitro 
PFC responses 
Expt. 1  Expt. 2 
None  +  2,055 _  87  1,950 +  250 
None  -  450 _  27  200 +  15 
Anti-Thy-l.2 + complement  +  480 +  57  ND 
Anti-Lyt-2 + complement  +  2,640 _  93  ND 
Medium alone + complement  +  2,610 +  126  ND 
Irradiation* (750 R)  +  555 =1= 81  500 +  35 
* Cobalt radiation source used. 
the lymphocyte  transformation  assay, we performed  two additional  experiments. 
The  results  of  these  two  experiments  (Table  II,  Fig.  1)  clearly  indicate  that  a 
Lyt-2- proliferating  T  cell provides  AChR-specific  help.  In the first experiment, 
AChR-immune  lymph  node  cells were  either  treated  with antibody  plus comple- 
ment  or irradiated  and  recounted,  and  2.5  x  10 5 of these cells were  mixed  with 296  SUPPRESSION  OF  IN  VITRO  ACETYLCHOLINE  RECEPTOR  RESPONSE 
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FIGURE  1.  AChR-specific  proliferating  cell  provides  AChR-specific  help.  AChR-induced 
proliferating cells were collected from a 3-d culture and blast cells were enriched on Lympho- 
prep.  Varying numbers of these cells were co-cultured with 1 ×  10  6 naive splenocytes with 
either NIP-AChR or an irrelevant antigen (NIP-(T,G)-A--L).  ~PFC responses represent the 
difference of the two groups for each cell concentration. 
7.5 x  105 naive splenocytes in a  MishelI-Dutton assay. As indicated in Table II, 
helper T  cell responses are sensitive to anti-Thy-1.2 but not anti-Lyt-2. In order 
to assess the relationship of AChR-specific T  cell proliferation to AChR-specific 
T cell help, proliferation was prevented by irradiation. As can be seen, irradiation 
with 750 rad completely blocked helper function. 
Instead of deleting the helper T  cells, we also tried the opposite experiment, 
namely,  positive selection of AChR-specific proliferating  cells and  their  subse- 
quent  functional  analysis.  AChR-primed  lymph  node  cells  were  placed  in  a 
proliferative assay for 3 d and collected, and blast cells were further enriched by 
centrifugation  on  Lymphoprep.  After the  3-d culture,  ~25%  of the cells were 
viable  and  11%  were  recovered  after  Lymphoprep  gradient  centrifugation. 
These cells were then added to naive splenocytes in different ratios in Mishell- 
Dutton assay conditions.  NIP-AChR or an irrelevant  antigen  (NIP-(T,G)-A--L, 
0.005 gg/ml) were added to the cultures and PFC responses were counted 5 d 
later. The results (Fig.  1) show that these "proliferating" cells provide substantial 
AChR-specific help. 
In  Vivo-educated AChR-specific Suppression.  Injection  of soluble  antigen  has 
traditionally  been  one  method  used  for  induction  of tolerance  and  Ts  cells. 
Although  injection of soluble AChR did not induce tolerance even if deaggre- 
gated (data not shown), we found that Ts cells were induced by this immunizatior 
regimen.  This  suppression  could be demonstrated  with  both whole cells from 
AChR-immune  mice (primed with soluble AChR as described in Materials and 
Methods) or with a  secreted cell product from these AChR-specific suppressor 
cells. The AChR-specific TsF was obtained in the supernatant  of a  2-d culture 
of AChR-immune splenocytes that were cultured without any antigen  (AChR). 
Table III shows our results using the TsF in an AChR, as well as in a NIP-HGG 
assay  system.  Moreover,  we  checked  the  effect  of supernatants  from  naive 
splenocytes. As seen in the Table, the TsF suppressed only the anti-AChR  PFC BOGEN,  MOZES,  AND  FUCHS 
TABLE  III 
In Vivo-educated Ts Factor 
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AChR system:  NIP-HGG System 
Anti- 
gen  Expt. 1  Expt. 2 
added  Factor (dilution)  Sup- 
to as-  Sup-  PFC/cul-  Sup-  PFC/culture  pres. 
say  PFC/culture  pres.  pres-  sion 
sion*  ture  sion 
%  %  % 
+  None  1,950:1:250  --  2,055 :l: 86  --  1,025:1:100  -- 
-  None  200:1:15  --  330 + 60  --  450 _+ 68  -- 
AChR-TsF 
+  1:10  400 :!: 130  89  ND  --  1,250:1:180  <0 
+  1:20  1,400:1:60  31  600 + 96  84  1,400:1:135  <0 
+  1:40  1,200 4- 115  43  1,440:1:57  36  1,275 +  153  <0 
+  1:80  1,300:1:220  37  1,290:1:57  44  ND  -- 
Control supernatant* 
+  1:10  1,950 :lz 210  0  ND  --  ND  -- 
+  1:20  2,500:1:430  <0  ND  --  ND  -- 
+  1:40  2,000 4- 165  <0  ND  --  ND  -- 
* Percent suppression was calculated as: (PFC assay positive control -  PFC suppressor cell group)/ 
total assay APFC. Assay positive control is the group containing assay cells plus antigen but without 
Ts cells. Total assay APFC is the difference of the PFC counts of assay cells cultured with and 
without antigen. 
* Control supernatant was generated in an identical manner as AChR-TsF except that the mouse 
used was not immunized. 
response and did not suppress an unrelated (NIP-HGG)  system. Moreover, naive 
supernatants also had no effect on the anti-AChR  PFC response. Therefore,  we 
conclude that our TsF is specific for the AChR. 
In  Vitro-educated  Ts and  TsF.  In  parallel to  the  studies  on  in  vivo-educated 
suppression, we also developed  the means to induce AChR-specific Ts cells and 
TsF  from naive cells in vitro. Although  the in vitro procedure  is more  difficult 
due to serum-related background  suppression (see below), it carried an important 
advantage.  It serves as a  model  for Ts cell induction in systems where  immuni- 
zation is not possible, namely,  for potential induction of human  AChR-specific 
Ts cells. 
We found that in vitro induction of AChR  Ts cells was dependent  on the dose 
of AChR  used  for  education  as  well as  the  number  of cells transferred  to  the 
assay. Our  procedure  as presented  in  Materials and  Methods  was based on  the 
methods used in the SE (13) and keyhole limpet hemocyanin (KLH) (14) systems. 
Naive splenocytes were cultured  with  AChR  for 4  d, at which  time  1  x  10 5 of 
these educated cells were added to 1 ×  10 6 assay cells in a  Mishell-Dutton culture. 
For a  comparison, a  group of 1  ×  10 6 assay cells alone was also included.  Fig. 2 
shows  the  role  of AChR  concentration  as  a  function  of the  subsequent  PFC 
response.  The  results indicate virtually complete suppression  of the anti-AChR 
immune  response  in vitro.  Eardley and  Gershon  (13)  found  that  removal of 2- 
ME was helpful during SE-specific Ts induction. In our AChR  system, however, 
we found that medium  with 2-ME was superior (Fig. 2). 298  SUPPRESSION  OF  IN  VITRO  ACETYLCHOLINE  RECEPTOR  RESPONSE 
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FIGURE 2.  Role of the AChR concentration used for Ts induction. Naive splenocytes were 
incubated with the indicated AChR concentrations as described in Materials and Methods. Ts 
induction was done in the presence (O----~) or absence (O----O) of 5 X 10 -e M 2'ME.  1 x 
l0  s of these precuhured cells were then added to a  Mishelt-Dutton assay and PFC responses 
counted 5  d  later.  The  shaded bars  are  the  positive and  negative controls of the assay, 
representing the PFC counts of 1 X 106 assay cells with and without antigen, respectively. 
70 
§  60 
Q_ 
"6 
4G 
50 
2(1 
IC i  ~'~ 
5xlO 4  I04  5xlO 3 
Number of Educated Cells 
FIGURE 3.  Role of the number of precultured cells transferred to the Mishell-Dutton assay. 
Varying numbers of cells cultured with (O---------O)  or without (0---0)  AChR (4 t~g/ml) were 
added to a  Mishell-Dutton assay.  Percent suppression was calculated as in Table IlI. Total 
APFC =  2,850. 
Fig.  3  demonstrates the relationship of the number of educated cells trans- 
ferred as a function of suppression. In this experiment, naive splenocytes were 
educated with or without AChR (4 ~g/ml) for 4 d and varying numbers of these 
precultured cells were added to a Mishell-Dutton assay. As can be seen, although 
105 cells yield some nonspecific suppressive background (from Fig. 2), it rapidly 
disappears  with lower cell doses.  AChR-specific suppression is at least fivefold BOGEN,  MOZES,  AND  FUCHS  299 
greater than this background. 
In order to characterize the AChR-specific Ts and to distinguish its character- 
istics  from  those  of the  nonspecific  Ts  cells  causing  the  background  level  of 
suppression,  we performed two further  experiments (Table IV;  Fig.  4).  Table 
IV describes two surface markers of the AChR-specific Ts cells. In this experi- 
ment educated Ts cells were treated with the indicated antibodies and comple- 
ment and 5  x  104 of these cells were added per well to a  Mishell-Dutton assay. 
The results indicate  that  the AChR-specific Ts cell bears both the Thy-l.2  as 
well as Lyt-2 cell differentiation markers. 
We  then  attempted  to  determine  whether  the  background  suppression  ob- 
served with high numbers of cells precultured without antigen could be due to 
cells with specificities to FCS proteins.  If so, it would clearly suggest that  such 
cells are  also induced  in  a  manner  similar  to the  AChR-specific cells,  but are 
specifc to serum antigens,  not the AChR.  For that,  "control" cells which were 
cultured without AChR for 4 d were collected and incubated first on a goat anti- 
mouse Ig plate as described in  Materials  and  Methods,  and  then  plated in  an 
FCS-coated  plate.  Of  the  cells  obtained  after  the  goat  anti-mouse  Ig  plate 
(nonadherent),  9%  were  in  the  FCS-adherent  fraction  and  91%  in  the  FCS 
nonadherent  fraction.  These  two fractions,  as well as the  FCS-unfractionated 
TABLE  IV 
Characteristics of In Vitro-educated AChR-specific Suppressor Cells 
NIP- 
Sup- 
Treatment of AChR-specific Ts  AChR  PFC/culture  pres- 
cells  added to  sion* 
assay 
% 
No Ts cells  +  3,990 _  144  -- 
No Ts cells  -  1,140 :t= 102  -- 
Medium +  complement  +  1,530 +  69  86 
Anti-Thy-l.2 +  complement  +  3,720 +  342  9 
Anti-Lyt-2 +  complement  +  4,020 _  138  <0 
* Percent suppression was calculated as in Table III. 
I x 10  5  AChR-specific 
Ts Cells 
I xlO  5  Non-specificTs 
Cells: 
FC$  Adherent  ~/~J  --~ 
FCS Nonodherent 
I  [  1  I  I  I  I  I  I  I 
I0  2O  5O  4O  50  6O  7O  8O  90 
%  Suppression  of  PFC  Response 
FIGURE  4.  4-(1 "control" cells (no AChR in vitro for Ts induction) were depleted of adherent 
and B cells. 1 ×  105 of these cells were added to a  Mishell-Dutton culture (FCS unfractionated) 
and the remainder to a  FCS-coated plate. Adherent and nonadherent fractions were assayed 
for  suppressive activity,  1  x  105  cells  per  well.  For  comparison,  AChR-educated  Ts  cells 
derived  from  the same spleen cell  population  were  also checked.  Percent  suppression was 
calculated as in Table III. Total APFC -- 2,745. 300  SUPPRESSION  OF  IN  VITRO ACETYLCHOLINE RECEPTOR  RESPONSE 
TABLE V 
Specificity of In Vitro-educated Ts Factor 
AChR-system  NIP-HGG system 
Anti- 
gen in  Factor  Sup- 
assay  PFC/culture  pres-  PFC/culture  Su.p-  presslon  sion* 
%  % 
+  None  1,950 ± 250  --  1,080 ±  104  -- 
--  None  200 ±  15  --  225 ± 81  -- 
+  TsF-AChR: unfractionated  750 ±  100  69  405 ±  104  79 
+  effluent from Sepharose-FCS*  1,050 ±  115  51  990 _+ 126  11 
+  effluent from Sepharose-AChR!  2,200 +  115  <0  ND  -- 
+  eluate from Sepharose-AChR  1,150 ±  180  46  1,080 ± 32  0 
+  TsF-Control: unfractionated  530 ± 30  81  ND  -- 
+  effluent from Sepharose-FCS  1,533 ± 77  22  ND  -- 
* Percent suppression was calculated as in Table III. 
* The dilution of all fractions was 1:40 based on the original volume of the supernatant. 
0 The effluent of the Sepharose-FCS column was applied to the Sepharose-AChR column. 
cell  population  were  added  to  an  anti-AChR  Mishell-Dutton  assay,  1  x  105 
precultured  cells to each well.  Fig.  4  summarizes the results.  The  background 
level of suppression that is found at high cell doses (38% in this experiment) was 
greatly enriched on the FCS-coated plate, clearly suggesting that there are FCS- 
specific cells  involved  in  this background  effect.  AChR-specific  suppression  at 
this cell dose in this experiment was 84%. 
Suppressor T  cell supernatants from in vitro-educated Ts cells were also found 
to contain an AChR-specific TsF. This factor was antigen-specific since it absorbs 
to  and  is  eluted  from  a  Sepharose-AChR  column.  Moreover,  the  eluate  was 
found  to  have  no  effect  in  an  irrelevant  (NIP-HGG) assay  system (Table  V). 
Similar to our results in using whole cell preparations,  control supernatants (no 
AChR in vitro) were also suppressive. However, as seen in Table V, most of the 
nonspecific  suppression  in  the  control  supernatant  effluent  was removed by a 
Sepharose-FCS column. In addition, the nonspecific suppressive effect contained 
in  the  supernatant  of AChR-educated  Ts  cells  (TsF-AChR)  was  removed  by 
passage  through  a  Sepharose-FCS  column.  The  effluent  from  such  a  column 
retained  its AChR-specific suppressive activity, whereas it was ineffective in an 
irrelevant NIP-HGG system (Table V). 
Discussion 
During  the past decade,  the  understanding  of immunoregulatory events fol- 
lowing injection with experimental antigens has leaped forward at an impressive 
rate.  Much  of this progress is undoubtedly due  to the development of suitable 
assay  systems such  as  those  described  by  Mishell  and  Dutton  using  SE as  an 
antigen  (7).  Application  of this  assay  to  the  study  of autoimmunity  is  thus  a 
desirable  goal  and  was  made  possible  in  our  system because of the  fortuitous 
availability of high concentrations of AChR in the electric organ of the electric 
fish that can be purified by affinity chromatography techniques (8). 
The present report describes an in vivo and in vitro model system of AChR- BOGEN, MOZES, AND FUCHS  301 
specific suppressor T  cell and T  cell factor induction. The results of this work 
are of special importance since they relate to an antigen directly involved in the 
human  autoimmune  disease  myasthenia  gravis.  Although  human  antigen 
(AChR)-specific immunotherapy may be still  far off, we believe that this work 
represents  the  required  first  step--development  of the  appropriate  in  vitro 
model systems. 
We also describe a reliable and reproducible in vitro assay system that models 
the anti-AChR immune response on a T  cell level. This assay is essential for the 
measurement of AChR-specific suppressor T  cell and T  cell factors. As already 
mentioned, the lymphoproliferative assay was unsuitable for this type of work. 
For example, we found that when AChR-specific suppressor T  cell preparations 
were placed in a lymphoproliferative assay, they themselves proliferated. If these 
suppressor T  cells were irradiated in order to prevent their growth, no suppres- 
sion resulted since suppressor T  cells have been shown to be radiosensitive (13). 
Suppressor T  cell factors were also nonspecificaily mitogenic due to the FCS. 
Our first attempts for the adaptation of the Mishell-Dutton assay to the AChR 
system involved exposing AChR-primed lymphocytes to AChR (not NIP-AChR) 
and measuring the anti-AChR activity in the supernatants following removal of 
the added antigen. We found that, while different doses of AChR in vitro could 
modulate  anti-AChR  activity,  as  was  also  reported  by  De  Baets  et  al.  (15), 
background levels of antibody (no AChR added in vitro) were highest of all. 
Presumably, plasma cells generated in vivo following immunization with AChR 
in  CFA  continued  to  secrete  antibody  in  vitro.  Therefore,  we  adopted  the 
hapten-carrier approach whereby we measure a primary anti-NIP B cell response. 
This  has  the  advantage  of low  backgrounds  and  large  responses  in  positive 
cultures, usually of a  5-10-fold magnitude. In this manner, we can be sure of 
studying a secondary AChR-specific T  cell in vitro response rather than events 
which occurred in vivo. The finding that we could obtain a  primary anti-NIP 
response  while  the  T  cell  response  was  secondary in  nature  is  in  complete 
agreement to the results of Schreir (16).  In an analysis of the in vitro antibody 
response,  he  found that  T  cells,  not  B  cells,  were the limiting cell  type in  a 
primary in vitro immune response. 
Using the  Misheli-Dutton  assay,  we have shed light on  the function of the 
"proliferating" cell measured in the lymphoproliferative assay. By both positive 
and negative selection techniques, we show that the Lyt-2- proliferating T  cell 
provides AChR-specific help. It is still possible that two (or more) cell types, both 
Lyt-2-, are necessary in providing help and only one is inactivated by irradiation. 
In this regard, Agarossi et al. (17) found two separate helper T  cell subpopula- 
tions that differed in their radiosensitivity. Other groups have also found two 
types of helper T  cells that can act  independently or synergistically (18,  19). 
Another group described two helper T  cell preparations that differed in their 
radiosensitivity (20). Whereas the radiosensitive one acted in an antigen-specific 
manner, the radioresistant preparation was largely antigen-nonspecific. We thus 
conclude that our lymph node preparations probably contain mainly the radi- 
osensitive type of helper T  cell. 
Our results on the characteristics of the AChR-specific helper T  cell are in 
agreement with those obtained by others using the lymphoproliferative assay in 302  SUPPRESSION  OF  IN  VITRO  ACETYLCHOLINE  RECEPTOR  RESPONSE 
mice (91) and rats (15). They both found that a cell type with surface differen- 
tiation markers associated with helper T  cells was the cell type responsible for 
tritiated thymidine uptake. Namely, the Lyt-1 + 23- phenotype in mice and the 
W3/25 ÷ phenotype in rats were implicated in the lymphoproliferative response. 
The latter report also demonstrated that when the W3/25 + subset was deleted 
by separation in the FACS, no anti-AChR antibody was synthesized in vitro by 
the remaining W3/25-  cells.  Our  results  thus complement and  extend these 
others,  as  we have both  positively and  negatively selected the AChR-specific 
proliferating cell type in an assay system designed to directly examine the function 
of the cell preparation. 
The main topic of this paper deals with the strategies that we found successful 
in inducing AChR-specific Ts cells and TsF. The in vivo education method was 
presented because of its simplicity and freedom from nonspecific suppression. 
As  demonstrated using the  in  vivo-educated TsF,  the predominant cell  type 
induced was the AChR-specific Ts cell. In vitro education of naive splenocytes 
was demonstrated to be another effective method for the induction of AChR- 
specific suppression. The batch of FCS, however, was critical in order to minimize 
serum-specific suppression. With many batches of FCS, we found that precultured 
cells that  were not exposed to  AChR completely suppressed in vitro immune 
responses after transfer into a Mishell-Dutton assay. This did not occur with the 
in  vivo-educated  TsF  because  of a  difference in  kinetics.  Whereas  in  vivo- 
educated Ts cells were cultured for only 2 d to obtain their TsF, at least 3 d are 
required for primary induction of both specifc (13) and nonspecific (10) Ts cells. 
Slight levels of background suppression were also reported by other investi- 
gators (13).  The cause of the background suppression,  as suggested by Parish 
(10), was due to induction of Ts cells to proteins in the FCS. Our results from 
panning of FCS-binding cells as well as studies with FCS-binding TsF both lead 
us to the same conclusion. Ts cells may be induced to proteins in the FCS in the 
same manner as those induced to the AChR. These FCS proteins are presumably 
passively adsorbed by helper T  cells in the in  vitro anti-AChR assay and thus 
serve as targets for serum-specific suppression. In spite of this difficulty, however, 
there was consistently a wide difference between the AChR-specific suppression 
vs.  background when using cell numbers below  1  ×  10 ~ (Fig.  3).  With factor 
experiments the specific and nonspecific suppression were separable due to their 
differential  adherence  to  the  Sepharose-FCS  and  Sepharose-AChR  columns 
(Table V). 
The  development of conditions  to  induce  AChR-specific Ts  cells  and  the 
means to measure them appropriately in  vitro opens the way to extend these 
findings to the in  vivo situation.  Thus,  it is now possible to study the state of 
AChR-specific suppression in experimental as well as human myasthenia. More- 
over, this work enables the development of long-term T  cell lines or hybridomas 
in the murine system, and the adaptation of the in vitro education procedure for 
human ceils. The availability of large amounts of AChR-specific Ts factors from 
such lines may be of potential use for immunotherapeutic intervention in myas- 
thenia gravis. BOGEN, MOZES, AND  FUCHS  303 
Summary 
This report describes the in vivo and in vitro induction of murine (AChR)- 
specific suppressor T  cells (Ts) and T  cell factors (TsF), and the development of 
an appropriate assay system for their measurement. The assay described is based 
on the in vitro Mishell-Dutton culture system. Using this assay, it was shown that 
the AChR-specific helper cell is an Lyt-2- radiosensitive T  cell. Moreover, the 
proliferating cell measured in the lymphocyte transformation assay was shown 
to provide AChR-specific T  cell help. In vivo induction of Ts cells is achieved by 
injection of soluble  AChR;  potent AChR-specific suppression  is  found in  the 
spleen 1 wk later. In vitro induction of Ts ceils involves the primary education 
of naive splenocytes by culturing them with high concentrations of AChR. Both 
the in vivo- and in vitro-induced Ts cells were shown to secrete AChR-specific 
factors  that  mediate  their  suppressive  effects.  The  possibility  of specifically 
suppressing the AChR-immune response may be of a particular clinical impor- 
tance since the AChR is the target autoantigen in the neuromuscular autoimmune 
disease myasthenia gravis. 
Received  for publication 12 September 1983. 
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